Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms

George D Giannoglou1, Yiannis S Chatzizisis, Chrysanthos Zamboulis

  • 11st Cardiology Department, AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece. yan@med.auth.gr

Insights

Elevated heart rate accelerates coronary atherosclerosis by increasing arterial wall stress and altering blood flow dynamics. Lowering heart rate may slow atherosclerosis progression and benefit heart disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Vascular Biology

Background:

  • Epidemiological studies link elevated heart rate to coronary atherosclerosis, independent of other risk factors.
  • The pathophysiologic mechanisms of heart rate's pro-atherosclerotic effects, beyond sympathetic tone, require exploration.

Purpose of the Study:

  • To review the pathophysiologic mechanisms by which elevated heart rate promotes atherosclerosis.
  • To highlight the clinical relevance of heart rate in coronary heart disease management.

Main Methods:

  • Review of existing epidemiological and pathophysiologic literature.
  • Analysis of hemodynamic and endothelial effects of increased heart rate.

Main Results:

  • Elevated heart rate increases tensile stress and prolongs exposure to low shear stress on the arterial wall.
  • Increased heart rate alters coronary artery geometry and local hemodynamics, inducing endothelial changes.
  • These cumulative changes promote atherosclerosis in susceptible regions.

Conclusions:

  • Elevated heart rate is a significant factor in atherosclerosis development.
  • Heart rate is a measurable parameter crucial for coronary heart disease patients.
  • Slowing heart rate may reduce atherosclerosis progression by improving the vascular environment, potentially benefiting heart disease prevention.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...